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Abstract
The present work describes the development of a fast and robust analytical method for 
the determination of 53 antibiotic residues, covering various chemical groups and some 
of their metabolites, in environmental matrices that are considered important sources of 
antibiotic pollution, namely hospital and urban wastewaters, as well as in river waters.
The method is based on automated off-line solid phase extraction (SPE) followed by 
ultra-high-performance liquid chromatography coupled to quadrupole linear ion trap 
tandem mass spectrometry (UHPLC-QqLIT). For unequivocal identification and 
confirmation, and in order to fulfil EU guidelines, two selected reaction monitoring 
(SRM) transitions per compound are monitored (the most intense one is used for 
quantification and the second one for confirmation). Quantification of target antibiotics 
is performed by the internal standard approach, using one isotopically labelled 
compound for each chemical group, in order to correct matrix effects. The main 
advantages of the method are automation and speed-up of sample preparation, by the 
reduction of extraction volumes for all matrices, the fast separation of a wide spectrum 
of antibiotics by using ultra-high-performance liquid chromatography, its sensitivity 
(limits of detection in the low ng/L range) and selectivity (due to the use of tandem 
mass spectrometry) The inclusion of ß-lactam antibiotics (penicillins and 
cephalosporins), which are compounds difficult to analyze in multi-residue methods due 
to their instability in water matrices, and some antibiotics metabolites are other 
important benefits of the method developed. 
As part of the validation procedure, the method developed was applied to the analysis of 
antibiotics residues in hospital, urban influent and effluent wastewaters as well as in 
river water samples.  
Keywords: antibiotics, ultra-high-performance liquid chromatography, quadrupole-
linear ion trap, multi-residue analytical method, analysis of hospital and urban 
wastewater, analysis of river water. 
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Introduction
Various types of pharmaceutical residues are being constantly detected in environmental 
waters (waste, surface and drinking water) at relatively low concentrations. Recent 
research investigations pointed out that some pharmaceuticals (and within this group 
antibiotics are included) can exert adverse ecological and human health effects even at 
the low concentrations found in the environment [1-3]. Furthermore, some PhACs such 
as antidepressants and antibiotics can be prone to bioconcentration/bioaccumulation in 
aquatic organisms, particularly in fish [4-7]. Antibiotics are one of the pharmaceutical 
classes with higher usage and consumption worldwide. They are widely used in both 
human and veterinary medicine mainly for treating bacterial infections. However, 
besides their therapeutic usage, they are also used as growth promoters in livestock 
animal production, as feed additives in fish farming and as coccidiostatic drugs in the 
poultry industry [8]. 
The most notorious and significant negative effects attributed to the occurrence of 
antibiotics is the development of antibiotic resistance [9-12]. While antibiotic-resistant 
bacteria are found in the natural environment, significantly higher numbers of these 
bacteria are present in wastewater or even in treated wastewater [8]. Some studies 
indicated that WWTP can serve as potential reservoirs of antibiotic resistance genes 
which can be transferred to human-associated bacteria through water and food webs, 
and thus contribute to antibiotic resistance proliferation [9,13]. Indeed, some studies 
revealed that WWTP discharges can be an important vehicle of antibiotic-resistance in 
natural waters [14] and in soils irrigated with wastewater effluents [13]. Antibiotic 
resistant genes have even been found in drinking waters [10,15]. Furthermore, it was 
observed that differences in treatment plant designs and their operation may influence 
the fate of resistant bacteria and resistance genes in wastewater [8,16-18]. 
In this context, it is important to set up fast, sensitive and reliable analytical methods
that enable the determination of a wide range of antibiotic residues in environmental 
waters, such as hospital, urban wastewater and river waters, at the low concentration 
levels that they are found. These methods are particularly needed to support the studies 
dealing with the proliferation of antibiotic resistance in environmental waters polluted 
by antibiotic residues, in order to draw correlations between their presence and the 
occurrence of antibiotic resistance genes. 
Nowadays, a large number of multi-residue analytical methods are already available for 
the determination of a wide spectrum of antibiotics in foodstuffs of animal origin [19-
21], such as milk [22-24], eggs [25], honey [26] animal muscle [27] and meat [28], 
among others.  Regarding water matrices, the vast majority of existing multi-residue 
methods generally include sulfonamides, trimethoprim, nitroimidazole antibiotics [29]
whereas the methods that also take into account several ß-lactam antibiotics (penicillins 
and cephalosporins) are more scarce [30,31]. Zhou et al. [32] recently developed a 
multi-residue method to determine a wide range of antibiotics in several aqueous and 
solid environmental matrices. However, in this methodology, only one penicillin and 
cephalosporin antibiotic was taken into account. Furthermore, the vast majority of 
analytical methods published in the literature, focus their attention on parent antibiotics
and rarely include metabolites. The addition of metabolites is of special interest since 
they can be still bioactive, they can be found at higher concentrations than the original 
substance and they may have high stability and mobility in the environment. 
In all these methodologies, the instrumental technique per excellence is liquid 
chromatography coupled to tandem mass spectrometry. The cost-effectiveness of 
analytical procedures is becoming a priority issue in all current experimental designs. 
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The goal is to maximize the number of compounds that can be determined in a single 
simple procedure, by developing multi-residue methods, to increase sample throughput 
(by reducing chromatographic analysis time), to minimize sample manipulation (by 
automating sample preparation devices and decreasing sample volumes used) and to 
increase method efficiency, in terms of selectivity and sensitivity. 
With respect to liquid chromatography, the current trend involves the use of ultra high 
performance liquid chromatography (UHPLC). One of the drivers for the growth of this 
technique has been the evolution of packing materials used in the columns for the 
chromatographic separation. The underlying principles of UHPLC are governed by the 
van Deemter equation. According to this equation, by decreasing the particle sizes of 
the stationary phase in the analytical column to sub-2-μm, there is a significant gain not 
only in efficiency but also this efficiency does not diminish at increased flow rates or 
linear velocities. In this way, a much faster chromatographic separation of a large 
number of compounds can be achieved, in comparison with conventional HPLC, 
together with narrower peaks, improved sensitivity and higher resolution. On the other 
hand, since chromatographic efficiency is proportional to the column length and 
inversely proportional to the particle size, columns can be shortened by the same factor 
as the particle size without loss of resolution. Then, by using a flow rate three times 
higher than in HPLC, due to smaller particles, and shortening the column by one third 
(again due to smaller particle sizes), the separation can be completed in 1/9 the time 
invested in HPLC while maintaining resolution.
Concerning tandem mass spectrometry, current trends are focused towards the use of 
hybrid tandem mass spectrometers, such as quadrupole-time-of-flight (QqTOF) and 
quadrupole-linear ion trap (QqLIT), due to the advantages offered in comparison with 
triple quadrupole tandem mass spectrometers. While QqTOF instruments provide high 
confidence in compound identification due to exact mass measurements, evidence on 
isotopic patterns and their capability to distinguish isobaric mass interferences, QqLIT 
mass spectrometers can operate in a wide variety of scan modes, which can be 
combined in one single experiment through the Information Dependent Acquisition 
(IDA) function [33]. Furthermore, these instruments offer high sensitivity equal or even 
higher than triple quadrupole instruments [34] and when operating under SRM mode, 
large number of transitions can be monitored within one single retention time window 
[35].  
The present work describes the development of an analytical method based on 
automated off-line solid phase extraction (SPE) followed by ultra-high-performance 
liquid chromatography coupled to quadrupole-linear ion trap (QqLIT) tandem mass 
spectrometry, for the fast and simultaneous determination of 53 multiple-class 
antibiotics as well as some of their metabolites in hospital and urban wastewater and in 
river water. Antibiotic classes cover various chemical groups such as fluoroquinolones, 
quinolones, penicillins, cephalosporines, macrolides, tetracyclines, lincosamides, 
sulfonamides, dihydrofolate reductase inhibitors and nitroimidazoles. Target antibiotics 
were selected because of their high human and veterinary usage worldwide as well as 
their high occurrence and ubiquity in the aquatic environment, according to the 
information found in the scientific literature. 
For unequivocal identification and confirmation two Selected Reaction Monitoring 
(SRM) transitions were monitored per compound. Quantification was performed by the 
internal standard approach, by using isotopically labeled antibiotics, which is 
indispensable to correct matrix effects. 
The work presented in this manuscript offer several advantages such as: (i) the 
minimization and speed-up of sample manipulation by automating the sample 
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preparation step and by using low sample volumes (i.e. 25 mL for influent wastewaters, 
50mL for hospital and urban effluent wastewater and 100 mL for river waters), (ii) the 
inclusion of antibiotic metabolites (methods already available focus their attention on 
parent compounds and rarely include metabolites) and (iii) its high sensitivity when 
working in the Selected Reaction Monitoring (SRM) mode (limits of detection are in the 
low ng/L range, even though less sample volumes for sample pre-concentration are 
used) and (iv) the inclusion, with good analytical performances of penicillins and 
cephalosporins in the multi-residue method (these compounds are quite unstable in 
water medium and therefore they present several difficulties in their analysis in water 
matrices, especially for their analysis in multi-residue methodologies). 
Finally, the developed method was successfully applied to the analysis of antibiotics 
residues in hospital, waste and river waters from one hospital, several WWTPs and river 
waters in the area of Catalonia (North East of Spain). Results indicate that antibiotics
are widespread pollutants in these types of matrices. 
2. Materials and methods
2.1. Chemicals and reagents
All antibiotic standards were of high purity grade (>90%).  All compounds were 
purchased from Sigma-Aldrich. According to table 1, substances with number 33, 34, 
36 and 38 were purchased as hydrochloride salts, compounds with number 19, 21, 22 
and 25 were acquired as sodium salts, substances with number 16 and 17 as potassium 
salt, antibiotics with number 14 and 15 were purchased as trihydrate salts and 
compounds with number 30 and 35 were acquired as tartrate and hyclate salts, 
respectively. Isotopically labeled compounds, used as internal standards, were, 
ofloxacin-d3, ciprofloxacin-d8 (as hydrochloride hydrate salt), erithromycin-N,N-
dimethyl-13C, ampicillin-15N and ronidazole-d3, purchased from Sigma-Aldrich, and
azithromycin-d3, sulfamethoxazole-d4 and lincomycin-d3, which were purchased from 
Toronto Research Chemicals (Ontario, Canada). On the other hand, sulfadimethoxine-d6
and sulfadoxine-d3, which were used as surrogate standards, were purchased from 
Sigma-Aldrich. 
Individual stock standard, isotopically labeled internal standard and surrogate standard 
solutions were prepared at a concentration of 1000 mg/L, by dissolving 10 mg of solid 
reference standard in 10 mL of an appropriate solvent. Thus, the cephalosporins and 
penicillins cefalexin, cefazolin sodium salt, cefatoxime sodium salt, cefapirin and 
amoxicillin trihydrate were dissolved in HPLC water whereas cefuroxime sodium salt, 
ceftiofur, ampicillin trihydrate, penicillin G and penicillin V potassium salts were 
dissolved in AcN/H2O (50:50 v/v) whereas oxacillin sodium hydrate was prepared using 
HPLC/MeOH (50:50 v/v), as described in Kantiani et al. [36]. The rest of compounds 
were dissolved in methanol. However, the addition of 100 μL NaOH 1M was necessary 
for the proper dissolution of fluoroquinolone and quinolone antibiotics as described by 
Ibáñez et al. [30]. 
After preparation, standards were stored at -20ºC. Special precautions have to be taken 
into account for tetracyclines, which have to be stored in the dark in order to avoid their 
exposure to light, since it has been demonstrated that tetracycline antibiotics are liable 
to photodegradation [37]. In addition, to ensure stability of penicillins and 
cephalosporins different aliquots were used for each freeze-thaw cycle (each aliquot is 
used only once when preparing working standard solutions), as recommended in 
Kantiani et al. [36]. Fresh stock antibiotic solutions were prepared every six months 
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while fluoroquinoles and quinolones were prepared every two-three months and 
penicillins and cephalosporins monthly, due to their limited stability.
Working standard solutions, containing all antibiotics were prepared in methanol/ water 
(50:50, v/v) and were renewed before each analytical run by mixing appropriate 
amounts of intermediate standard solutions. Separate mixtures of isotopically labeled 
internal standards, used for internal standard calibration, and surrogates were prepared 
in methanol, with the exception of ampicillin-15N, which was diluted in HPLC 
water/AcN (50:50 v/v). Further dilutions were also prepared in a methanol/water (50:50, 
v/v) mixture.
The cartridges used for solid phase extraction were Oasis HLB (60 mg, 3 mL) and Oasis 
MCX (60 mg, 6 mL), both from Waters Corporation (Milford, MA, U.S.A.). Glass fiber 
filters (1 μm) and nylon membrane filters (0.45 μm) were purchased from Whatman 
(U.K.). HPLC grade methanol, acetonitrile, water (Lichrosolv) were supplied by Merck 
(Darmstadt, Germany). Ammonium hydroxide, hydrochloric acid 37% and 
ethylenediaminetetraacetic acid disodium salt solution (Na2EDTA) at 0.1 mol/L were 
from Panreac. Formic acid 98% was from Merck (Darmstadt, Germany). Nitrogen for 
drying was from Abelló Linde S.A (Spain) and it was of 99.9990% purity. A Milli-Q-
Advantage system from Millipore Ibérica S.A. (Spain) was used to obtain HPLC-grade 
water. 
2.2. Water samples collection, sample pre-treatment and analysis
The method was optimized using hospital wastewater, urban influent and effluent 
wastewater and river water. Specifically, hospital effluent wastewater was taken from 
Josep Trueta hospital, one of the main hospitals in the area of Girona (Catalonia, Spain), 
with 400 beds and that gives service to approximately 795363 people. Wastewater 
samples were collected from Girona’s wastewater treatment plant facility, which 
receives the wastewater coming from Josep Trueta hospital and treats water from an 
area of 143975 inhabitants, with a design of 206250 population equivalents. Besides 
hospital wastewater, this treatment plant also receives urban and domestic wastewater. 
It has a primary and secondary treatment operating with conventional activated sludge. 
On the other hand, river water for method optimization was taken from river Onyar, 
which crosses the city of Girona before flowing into the river Ter. 
For method validation, grab hospital and urban wastewater as well as river water were 
used. Amber glass bottles pre-rinsed with ultrapure water were used for sample 
collection. Hospital wastewaters were filtered through 2.7 μm followed by 1 μm glass 
fiber filters and after that, they were further filtered through 0.45 μm nylon membrane 
filters (Whatman, U.K.), whereas waste and river water samples were only filtered 
through 1 μm glass fiber filters and 0.45 μm nylon membrane filters. 
A suitable volume of a Na2EDTA solution, having a concentration of 0.1 M, was added 
to the different types of water to achieve a final concentration of 0.1% (g solute/g 
solution) and sample pH was adjusted to 2.5 with hydrochloric acid. Moreover, water 
samples were spiked, with an appropriate volume of a standard mixture containing 
surrogate standards, in order to have a concentration of 200 ng/L in urban influent 
wastewaters, 100 ng/L in urban and hospital effluent wastewaters and 50 ng/L in river 
water, respectively. 
Water samples were automatically extracted by a GX-271 ASPECTM system (Gilson, 
Villiers le Bel, France) using Oasis HLB cartridges (60 mg, 3 mL) for all types of 
matrices. SPE cartridges were conditioned with 5 mL of methanol followed by 5 mL of 
HPLC-grade water, acidified at pH 2.5 with hydrochloric acid, at a flow rate of 2
mL/min. 25 mL of urban influent wastewater, 50 mL of urban and hospital effluent 
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wastewater and 100 mL of river water were loaded onto the cartridge at a flow rate of 1
mL/min. After sample pre-concentration, cartridges were rinsed with 6 mL of HPLC 
grade water, at a flow rate of 2 mL/min, and were dried with air for 5 min, to remove 
excess of water. Finally, analytes were eluted with 6 mL of pure methanol at a flow rate 
of 1 mL/min. Extracts were evaporated to dryness under a gentle nitrogen stream and 
reconstituted with 1 mL of methanol/ water (50:50, v/v). Finally, 10 μL of a 1 ng/μL 
standard mixture containing all isotopically labeled standards were added in the extract 
before instrumental analysis for internal standard calibration. Labeled standards 
included in the internal standard mixture were ofloxacin-d3, ciprofloxacin-d8, 
ampicillin-15N, Erythromycin-N,N-dimethyl-13C, azithromycin-d3, lincomycin-d3, 
sulfamethoxazole-d4 and ronidazole-d3. 
2.3. Solid phase extraction optimization
To optimize the extraction method, the lipophilic/hydrophilic balanced Oasis HLB (60
mg, 3 mL) and the mixed reversed phase/cationic exchange sorbent Oasis MCX (60 mg, 
3 mL), both from Waters Corporation (Milford, MA, USA), were compared, operating 
under different conditions. To evaluate which of these experiments yielded higher 
recoveries of target antibiotics, preliminary experiments were performed with MilliQ 
water. In all cases, water samples were spiked with appropriate concentrations of a 
standard mixture containing all target antibiotics and surrogate standards. After that, an 
appropriate volume of a Na2EDTA solution to achieve a final concentration of 0.1% (g 
solute/g solution) was added to Milli-Q-water. For Oasis MCX cartridges, samples were 
acidified, prior to the extraction, with hydrochloric acid until pH=2.5, whereas for Oasis 
HLB two experiments were performed: (i) one with no sample pH adjustment and the 
other one by adjusting the sample pH at 2.5 also using hydrochloric acid. In the 
experiments where water samples were acidified, cartridges were conditioned with 5
mL methanol followed by 5 mL HPLC grade water acidified with hydrochloric acid at 
pH 2.5, while in the experiments carrie  out without pH adjustment, SPE cartridges 
were conditioned with 5 mL methanol and 5 mL HPLC grade water. In all cases, 50 mL 
of Milli-Q-water were loaded onto the cartridges at a flow rate of 1 mL/min, cartridges 
were washed with 5 mL of HPLC grade water and analytes were afterwards eluted at a 
flow rate of 1 mL/min, using 6 mL of pure methanol for Oasis HLB, whereas for Oasis 
MCX, 3 mL of pure methanol followed by 3 mL of 5% of NH4OH in methanol were 
used (these two solvents were pooled in one single collection vial). 
In all situations, cartridges were dried with air for 5 min, to remove excess of water, 
then extracts were evaporated to dryness under a gentle nitrogen stream and 
reconstituted with 1 mL of methanol/ water (50:50, v/v), adding an appropriate 
concentration of internal standard mixture, as described in the previous section. 
Comparing these experiments, Oasis HLB cartridges with sample acidification prior to 
extraction were the conditions providing higher recoveries for almost all antibiotics 
classes under study, and therefore, these conditions were the ones selected for further 
recovery experiments and analysis of water samples. 
2.4. Ultra-high-performance-ESI-(QqLIT) MS/MS analysis
Chromatographic separations were carried out with a Waters Acquity Ultra-
PerformanceTM liquid chromatograph system, equipped with two binary pumps system 
(Milford, MA, USA) using an Acquity HSS T3 colum (50 mm x 2.1 mm i.d., 1.8 μm 
particle size) for also from Waters Corporation. The optimized separation conditions 
were as follows: solvent (A) acetonitrile, solvent (B) HPLC grade water acidified at 
0.1% with formic acid at a flow rate of 0.5 mL/min. The gradient elution was: initial 
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conditions 5% A; 0–3.0 min, 5–70% A; 3.0-3.5 min, 100% A; 3.5–5.0 min, 100% A; 
from 5.0 to 5.1 return to initial conditions; 5.1 to 6.0, equilibration of the column. The 
sample volume injected was 5 μL. The UPLC instrument was coupled to a 5500 
QTRAP hybrid triple quadrupole-linear ion trap mass spectrometer (Applied 
Biosystems, Foster City, CA, USA) with a turbo Ion Spray source. Compound 
dependent MS parameters (declustering potential (DP), collision energy (CE) and 
collision cell exit potential (CXP)) were optimized by direct infusion of individual 
standard solutions of each compound at concentrations ranging from 20 to 50 μg/L. For 
quantitative purposes, two MRM transitions were monitored for each antibiotic and a
summary of the optimum SRM transitions and conditions is available in table 2. All 
transitions were recorded by using the Scheduled MRMTM algorithm with the purpose 
to increase sensitivity and to achieve reproducible chromatographic peaks. Target scan 
time (TST) was set at 0.25 seconds, with a MRM detection window of 20 seconds.
Resolution at the first quadrupole (Q1) was set at unit, and at the third quadrupole (Q3), 
it was set at low and the pause between mass ranges was 5 ms. Settings for source-
dependent parameters were determined by Flow Injection Analysis and are as follows: 
curtain gas (CUR), 30V; nitrogen collision gas (CAD) medium; source temperature 
(TEM) was 650ºC; ion spray voltage was 5500 V; ion source gases GS1 and GS2 were 
set 60 and 50V, respectively and entrance potential (EP) was set at 10. All data were 
acquired and processed using Analyst 1.5.1 software.  
Results and discussion
3.1. Solid phase extraction optimization
Figure 1 shows the recoveries of representative antibiotics of each chemical group in 
Milli-Q water under the different conditions and polymeric phases tested: (i) adding 
Na2EDTA prior to sample pre-concentration using Oasis HLB cartridges without 
sample pH adjustment (sample pH is around 4.5-5), (ii) adding Na2EDTA and adjusting 
sample pH at 2.5 before extraction, using also Oasis HLB cartridges, and (iii) adding 
Na2EDTA followed by sample acidification at pH 2.5 and extraction with Oasis MCX.
Na2EDTA was added in all protocols since the addition of a chelating agent, such as 
EDTA, oxalic or citric acid is recommended in the analysis of antibiotic residues in 
environmental samples [29]. The addition of the strong chelating agent, such as EDTA 
in water samples prior to extraction is mostly to complex metals or multivalent cations 
(residual metal ions) that are soluble in water, on SPE cartridges and glassware [37]. 
The antibiotics from the groups of tetracyclines, fluoroquinolones and macrolides have 
a high tendency to complex with those ions, resulting in lower extraction recoveries. 
The addition of the chelating agent is thus necessary to achieve good extraction 
efficiencies. 
Regarding polymeric cartridges, only Oasis MCX and HLB sorbents were tested since, 
based on the author’s previous experience, they are the ones yielding higher recoveries 
for a big number of pharmaceuticals [34], including antibiotics, and they are the ones 
mostly recommended in literature reviews for the analysis of different classes of 
antibiotics [29,37]. In fact, due to the chemical composition of Oasis HLB, which 
contain lipophilic divinylbenzene units and the hydrophilic N-vinylpyrrolidone units, 
allow the efficient extraction of organic contaminants in a wide range of pH (from pH 1 
to 14). 
On the other hand, the pH of the sample solution plays a significant role in the 
extraction efficiency of antibiotics. In the majority of multi-residue methods published 
so far, sample pH is generally adjusted within the range from 2.5 to 4 [29,38] to achieve 
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good extraction recoveries for the majority of chemical groups included. The
acidification of at least 2 units under pKa values of target analytes in water samples is 
recommended, in order to obtain their neutral or acidic forms, which may significantly 
improve their retention onto the SPE polymeric sorbent [38]. 
For this reason, in this work, the efficiency of Oasis HLB cartridges was tested at pH 
2.5 and without sample pH adjustment, while for Oasis Mixed Mode Cation Exchange 
(MCX) SPE extraction performance was only tested at low sample pH. This is, in fact, 
the recommended protocol for these cartridges, because at low pH values, basic, acidic 
and neutral substances can be retained in the mixed mode polymer (basic drugs are 
positively charged and therefore, they can be strongly bound to the polymer by positive 
cation exchanger, while neutral and acidic compounds are retained by reversed phase). 
As it is depicted in figure 1, in general terms, the methodology using Oasis HLB 
cartridges at low sample pH was the protocol that yielded higher recoveries for the 
majority of antibiotic classes whereas Oasis MCX was the one that showed worst 
performances. However, in some cases, differences between protocols were not 
significant (like for sulfonamides and fluoroquinolones), while in some other situations, 
Oasis HLB without sample pH adjustment showed better recoveries than the treatment 
with the same polymeric phase but with sample pH adjustment (especially for 
lincosamides and macrolides). Macrolide antibiotics contain a basic dimethylamine [-
N(CH3)2] group. Thus, according to their chemical structure, they are basic compounds 
with pKa values around 8, and probably, better extraction efficiencies would be 
expected at pH values higher than 2.5 [38].
For quinolones, recoveries achieved with Oasis HLB with and without sample pH 
adjustment were very similar, but performances decreased when using Oasis MCX 
cartridges. Quinolones contain a carboxylic group which makes all these compounds 
acidic, and they have only one pKa in the range between 6.0 and 6.9 [38]. Therefore, in 
acidic conditions they are in neutral form, having a good retention in Oasis HLB 
cartridges. 
Regarding fluoroquinolones, they have an amino group in the heterocyclic ring (namely 
piperazinyl), and they have two dissociation constants. The reported values of pKa1 and 
pKa2 are in the 5.5-6.3 and 7.6-8.5 range, respectively and thus, the intermediate form is 
a zwitterion. At acidic conditions they are in cationic form and it has been observed that 
cationic, zwitterionic and neutral species of these antibiotics are well retained on the 
polymeric Oasis HLB column [38]. Furthermore, due to their presence as cationic forms 
at low pH values would xplain the good extraction when using mixed mode polymeric 
phases (Oasis MCX). 
Concerning sulfonamides, they contain one basic amine group (-NH2) and one acidic 
sulfonamide group (-SO2NH-). They are ampholytes with weakly basic and acidic 
characteristics, having two pKa values, pKa1 (2-2.5) and pKa2 (5-8), respectively [38]. 
Thus, sulfonamides are positively charged at pH 2 and 5, and negatively charged at 
alkaline conditions above pH 5, explaining their good retention under all conditions 
tested. 
Major differences were observed for penicillins, chephalosporines and tetracyclines, 
showing higher recoveries when using Oasis HLB at low sample pH. In fact, penicillins 
and cephalosporines showed extremely low extraction recoveries when using Oasis 
MCX cartridges. One explanation could be that they degrade during the elution step, 
since methanol with ammonia is used, and it has been reported that these substances are 
prone to degradation under acidic and basic conditions [29]. Indeed, it is recommended 
to acidify the samples right before extraction, to avoid any analyte losses due to 
degradation. Even though neutral sample pH is the recommended protocol for the 
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analysis of penicillins and cephalosporines, in this case they showed better recoveries 
when acidifying the sample to pH 2.5 before extraction. Recoveries were even better 
than without sample pH adjustment, where sample pH is around 5. Good recoveries at 
sample pH around 2 and 3 are supported by other authors, who also found satisfactory 
recoveries for these substances under these conditions [30,39,40]. For tetracyclines, 
extraction at sample pH below their pKa (3.3-9) increases retention on the SPE 
cartridges [41]. 
The main objective of this work was to develop an extraction procedure that enables the 
simultaneous analysis of a wide range of multiple-class antibiotics in one single 
extraction step. Having that in mind and based on the results obtained, the extraction 
method based on Oasis HLB cartridges with sample pH adjustment and Na2EDTA as a 
cation complexing agent, was selected as the optimum protocol to apply to the multi-
residue extraction of antibiotic residues in several water matrices. Recoveries for 
hospital effluent wastewater, urban influent and effluent wastewaters and river water 
(mean of three replicates ±RSD) under the optimum conditions (Oasis HLB at low pH 
values) are given in table 3 and discussed in the method performance section.
3.2. Ultra-high-performance liquid chromatography separation optimization and 
QqLIT MS/MS Conditions for quantification and identification of antibiotics
In order to optimize chromatographic separation, different mobile phases and additives 
were tested. For the aqueous phase, buffered mobile phases consisting of 
formiate/formic acid at different concentration levels (5 mM and 10 mM at pH=3.2) and 
HPLC water with 0.1% formic acid were (FA) evaluated, whilst methanol and 
acetonitrile were tested as organic solvents. Only these mobile phases were tested 
because they are the ones mainly used in the analysis of multiple-class antibiotics
[29,37]. The use of acidic aqueous mobile phases is very common for the analysis of 
antibiotics, improving their ionization efficiency.  
To test which combinations of aqueous and organic mobile phases performed the best, a
linear gradient from 5% to 95% of organic solvent in 6min and a flow rate of 0.4 
mL/min were used as starting conditions. All these mobile phase combinations were 
tested using two different UHPLC columns: i) an Acquity HSS T3 column (50 mm x 2.1 
mm i.d., 1.8 μm particle size and ii) an Acquity BEH C18 column (50 mm x 2.1 mm i.d., 
1.7 μm particle size). These columns were tested because the Acquity HSS T3 column is 
recommended and can be a good choice when developing separations for highly polar 
and medium polar compounds, such as pharmaceuticals, while C18 stationary phases are 
the most common ones in the chromatographic analysis of antibiotics. In fact Acquity 
HSS T3 bonding utilizes a trifunctional C18 alkyl phase bonded at a ligand density that 
promotes polar compound retention and aqueous mobile phase compatibility. 
Furthermore, the proprietary T3 endcapping process is much more effective than 
traditional trimethylsilane (TMS) endcapping. This unique combination of bonding and 
endcapping provides superior polar compound retention and aqueous compatibility 
while also enhances column performance, lifetime, peak shape and stability. Columns 
with 50 mm length (50 mm x 2.1 mm) were used because the principal objective was to 
achieve fast separation, keeping a good resolution. 
Between all the combinations mentioned, the use of an Acquity HSS T3 column, with 
acetonitrile as organic phase and HPLC grade water containing 0.1% of formic acid as 
the aqueous phase were the conditions providing better resolution, peak shapes and 
responses. 
Once the best mobile phases and UHPLC column were established, the elution gradient 
and flow rate were adjusted and further optimized with the aim to improve 
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chromatographic resolution and peak shapes (by obtaining narrower chromatographic 
peaks) and to reduce total analysis time. In UHPLC, with the use of stationary phases 
containing small particles (typically <2 μm in size), chromatographic separation is 
performed with higher resolutions, sensitivities and reduced analysis time 
(chromatographic runs are approximately 3 times shorter than in HPLC). Furthermore, 
the use of UHPLC may help in reducing matrix effects produced by isobaric co-eluting 
sample compounds, thanks to the enhanced chromatographic resolving power provided 
by UHPLC in comparison with HPLC. The efficiency gained by using columns with 
particle sizes lower than 2 μm does not diminish at increased flow rates or linear 
velocities. Therefore, chromatographic separations are carried out at higher flow rates 
than in conventional HPLC, for increased separation speed. 
Different flow rates were tested (from 0.4 to 0.8 mL/min) and the optimum one was set 
to 0.5 mL/min. Finally, different temperatures were tested (30ºC, 40ºC and 50ºC). For 
the vast majority of pharmaceuticals, peak shapes and chromatographic response 
improved when 30ºC was used.  
It should be remarked that 100% organic content is kept during one minute in the 
elution gradient to clean the column and to avoid carry over contamination. In figure 2, 
the total ion current (TIC) chromatogram from a standard mixture and real samples 
containing some of the compounds analyzed are displayed.
Regarding tandem mass spectrometry analysis, [M+H]+ ions were selected as precursor 
ion. Two SRM transitions between the precursor ion and the two most abundant 
fragment ions were monitored for each compound, except for the isotopically labeled 
internal standards, which are not likely to be found in environmental matrices, and 
therefore, only one transition was monitored. The first transition is used for 
quantification purposes, whereas the second one is to confirm the identity of the target 
compounds. Besides the monitoring of the SRM transitions, other identification criteria 
were used for quantification: (i) the matching of the UHPLC retention time of the 
compound in the standard with those in the samples, (the retention time in the sample 
must be within ±2% the retention time of the compound in the standards), and (ii) the 
comparison between the relative abundances of the two selected analyte SRM 
transitions in the sample with those in the standards. These relative abundances in the 
samples must be within ±20% of the two SRM ratios in the analytical standards (see
table 2).
As mentioned before in section 2.4, all SRM transitions were monitored by using the 
Scheduled MRMTM algorithm. With this option, all SRM transitions of a certain analyte 
are monitored only around its expected elution retention time. Thus, automated SRM 
scheduling decreases the number of concurrent SRM transitions, allowing both the 
cycle time and the dwell time to be automatically optimized for the highest sensitivity, 
accuracy and reproducibility. In addition, this algorithm allows the monitoring of many 
more SRM transitions in a single acquisition run, which is especially important when 
using fast liquid chromatography, such as UHPLC, without compromising 
reproducibility and accuracy. Chromatographic peaks in UHPLC are much narrower, 
and thus, it is difficult to achieve enough points per peak when monitoring a large 
number of transitions by just using a fixed value for the dwell time for each SRM 
transition monitored. 
3.3. Method performance and matrix effects
The performance of the method was evaluated through the estimation of the linearity, 
extraction recoveries, sensitivity (by calculating instrumental detection limits, method 
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detection and quantification limits), repeatability and reproducibility as well as matrix 
effects. 
Quantification was based on linear regression calibration curves, by the internal 
standard approach. Regarding method performance in terms of dynamic range, linear 
response generally covered three orders of magnitude. Calibration curves gave good fits 
(r2>0.99) over the established concentration points ranging from 0.5 or 1 μg/L, to 50 or 
100 μg/L, depending on the compounds.  
Calibration standards were measured at the beginning and at the end of each sequence, 
and one calibration standard was measured repeatedly throughout the sequence, after 
every 20-25 samples, to check for signal stability. 
Instrumental limits of detection (IDLs) were estimated from signal to noise ratios 
(S/N=3) of low concentration calibration standards. IDLs ranged from 0.1 to 5 pg 
injected. These values indicate the high sensitivity of the mass spectrometer used and its 
capabilities to detect target antibiotics at the low concentrations found in complex 
environmental samples.  
Recoveries were determined by spiking hospital effluent wastewater, urban influent and 
effluent wastewater and river water, in triplicate, with two standard mixtures: (i) one 
containing penicillins and cephalosporins in HPLC grade water and (ii) another one 
containing sulfonamides, dihydrofolate reductase inhibitors, nitroimidazole antibiotics, 
quinolones, fluoroquinolones, macrolides, tetracyclines and lincosamides in methanol. 
The final spiking concentration in hospital effluent wastewater, urban influent and 
effluent wastewater was 400 ng/L while for river water it was 50 ng/L. These 
concentrations were selected as representative values since some antibiotics, like 
ofloxacin and ciprofloxacin can be found at high concentrations (high ng/L-low μg/L) in 
these matrices [39,42,43]. For river water, the spiking level selected was one order of 
magnitude lower than the one selected for wastewaters, since an important dilution 
factor occurs when pharmaceuticals enter surface waters. Moreover, for some 
compounds high method limits of quantification are achieved (around 50-100 ng/L) in 
wastewaters and therefore, these spiking levels were considered the most appropriate
ones for method validation purposes. 
Futhermore, it should be worth mentioning that although some of the target antibiotics 
(especially some tetracyclines and sulfonamides) are more frequently used in veterinary 
medicine, they have been also included as part of the method validation for hospital 
wastewaters.
The spiking mixture containing penicillins and cephalosporines was prepared freshly to 
ensure their stability. Moreover, this mixture was prepared in HPLC grade water to 
avoid the degradation that these substances can suffer in methanol [30]. In fact, extracts 
were eluted, evaporated and reconstituted just before analysis, to avoid the possible 
degradation of ß-lactam antibiotics in methanol as well as to ensure integrity of the 
sample extracts. Different proportions of methanol/water were selected to reconstitute 
sample extracts and the proportion consisting of methanol/water (50/50, v/v) was 
selected because it provided better chromatographic peak shape and sensitivity for 
macrolide and tetracycline antibiotics. However for the analysis of only penicillins and 
cephalosporines it would be more recommendable to reconstitute the extracts with pure 
HPLC grade water or mobile phase initial conditions. 
Relative recoveries were determined by comparing the concentrations obtained after the 
whole SPE procedure, calculated by internal standard calibration, with the initial 
spiking levels. Since water samples can contain target antibiotics, blanks (non-spiked 
samples) were also analyzed and the levels found subtracted from those obtained from 
spiked samples. Results for each matrix are presented in table 3. Generally, in all type 
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of waters analyzed, recoveries achieved for all target antibiotics ranged from 50 to over 
100% in some cases. However, some substances such as amoxicillin, penicillin G and 
hydroxyl-metronidazole in all water samples, oxacillin and orbifloxacin in urban 
wastewater influent and orbifloxacin, cinoxacin, oxolinic acid, penicillin G and V and 
ceftiofur in hospital effluent wastewaters showed low recovery rates (between 20 and 
30%, see table3). Low recoveries obtained for some penicillins can be explained by 
their unstability in water media, attributed to their chemical structure [38]. This is, in 
fact, one limitation of multi-residue methodologies, where not the best conditions for all 
target analytes are achieved and therefore, a compromise on the final analytical 
conditions has to be reached. The overall method precision, calculated as the relative 
standard deviation (%RSD) was satisfactory (see table 3), ranging from 1 to 15% in a 
general extent, with some compounds showing %RSD until 20% (see table 3).   
Method detection (MDL) and quantification limits (MQL) were estimated from the 
signal to noise ratio (S/N=3 for detection limits and S/N=10 for quantification limits) of 
real samples and recovery replicates (MDLs and MQLs were calculated as the average 
of those estimated in real samples and in the spiked samples). When antibiotics were not 
detected in real samples, they were estimated only from the spiked replicates. MDLs 
calculated for hospital and urban effluent wastewaters ranged from 1 to approximately 
30 ng/L, from 3 to 30 ng/L for influent wastewaters and from 0.5 to 15 ng/L for river 
waters, respectively. Higher MDLs were achieved for some substances, such as 
norfloxacin (55 ng/L in urban effluent wastewater and 78 ng/L in influent effluent 
wastewater), oxacillin (40 and 48 ng/L in hospital, urban effluent and influent 
wastewater, respectively), cefazolin (around 50 ng/L in hospital and urban effluent 
wastewater) and doxycycline (approximately 70 ng/L in urban influent and effluent 
wastewaters). Regarding MQLs, they ranged from approximately from 5 to 50 ng/L in 
both hospital and urban effluent wastewater, and from 10 to 60 ng/L for urban influent 
wastewater, with some exceptions such as danofloxacin, norfloxacin, oxacillin, 
cefazolin, doxycycline and tylosin, whose limits of quantification were around (and in 
some cases exceeded) 100 ng/L (for more details, see table 4). For river waters, MQLs 
were much lower than in wastewaters, roughly ranging from 1 to 50 ng/L. 
It is worth mentioning that with this method, low MDLs and MQLs were achieved for 
the vast majority of antibiotics, even though low sample volumes are used for a sample 
pre-concentration. By reducing the sample volume of complex samples, such as hospital 
and urban wastewaters, matrix effects may be decreased. In fact, the MDLs and MQLs 
calculated in this study are comparable to those obtained by other analytical methods 
where more volume has to be loaded for the SPE [30,31,41,44] and even very close to 
those obtained by using an on-line SPE instrumental system [45].
Run-to-run variations (repeatability) were assessed from 5 consecutive injections of a 
10 μg/L calibration curve standard, while day-to-day (reproducibility) variations were 
evaluated by measuring a standard over 3 consecutive days. The RSD values achieved 
for intra-day analysis were below 7%, with the exception for cefuroxime and 
doxycycline, showing RSD of 16 and 12%, respectively. Concerning inter-day analysis, 
RSD ranged approximately from 10 to 25%, with some exceptions (see table 3). 
Regarding matrix effects, they were only evaluated for complex matrices, namely urban 
(influent and effluent) and hospital wastewater To evaluate to what extent target 
compounds and isotopically labeled substances were sensitive to signal suppression or 
enhancement, matrix effects were evaluated using equation (1). According to this 
equation, the peak areas of urban and hospital wastewater extracts, all spiked with target 
antibiotics (area matrix), are first subtracted by the peak areas corresponding to the 
native analytes present in the sample (area blank). The values obtained are then 
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compared with the peak areas in the solvent (methanol-water 50:50, v/v) spiked with 
target antibiotics at the same concentration (area solvent). The spiked concentration was 
10 μg/L for all the matrices considered. 
(1)
Almost all compounds were subjected to ion suppression, with the exception of 
fluoroquinolone and quinolone antibiotics, which showed signal enhancement in all 
matrices. Furthermore, tetracycline antibiotics chlortetracycline, doxycycline and 
oxytetracycline also showed signal enhancement in urban influent and effluent 
wastewaters, tetracycline only in urban effluents and chlortetracycline in hospital 
effluent wastewaters. While antibiotics were subjected to significant ion suppression 
(even severe, up to 80 and 90% for some substances) in hospital and influent 
wastewaters, in effluent wastewaters the degree of ion suppression was significantly 
reduced (suppression was between 20 and 50%, being 50% the maximum value). For 
this reason, figures showing the percentage of ion suppression only in hospital 
wastewater and urban influent wastewaters are included. Therefore, in figures 3A and 
3B, representative antibiotics of each chemical group subjected to ion suppression are 
depicted, indicating the percentage of signal reduction in (A) hospital effluent 
wastewater and (B) urban influent wastewaters. Values presented in the figures 
correspond just to the wastewater samples used for method validation and this 
parameter should be evaluated with each set of samples analyzed. These results show 
that it is of high significance to use a plausible approach to correct these effects, in order 
to avoid inaccurate quantification (by overestimation or underestimation) when 
analyzing real samples. In this study, internal standard calibration including a wide 
range of isotopically labeled antibiotics was used as the strategy to correct matrix 
effects. Since no isotopically labeled standards were available for each antibiotic, one 
internal standard was selected for each chemical group. The criterion to select internal 
standards was based on their similarity with the compounds under study in terms of the 
mass spectrometric response, the chemical structure, the chromatographic retention time 
and the degree and type of matrix effects (it was checked that internal standards and 
analytes were affected by a similar degree of ion suppression or enhancement).  
3.4. Application of the method to the analysis of hospital and urban wastewaters and
river waters
To demonstrate the applicability of the analytical method developed, hospital 
wastewater, urban influent and effluent wastewater from three WWTPs, and five river 
waters, which receive the discharge of WWTPs, all located in the area of Girona, were 
analyzed. Hospital wastewater samples were collected from Josep Trueta hospital, 
which is one of the main hospitals in the area of Girona, with around 400 beds and that 
gives service to approximately 795.363 people. Grab samples were collected at two
different days, specifically in November 29th and December 12th 2011. 
Regarding wastewaters, three WWTP were monitored. The first one (WWTP1) 
corresponds to the WWTP located at the outskirts of Girona city, which treats water 
from an area of 143975 inhabitants, with a design of 206250 population equivalents, 
and it mainly receives urban, domestic and hospital wastewaters from Josep Trueta 
hospital. The second WWTP (WWTP2) corresponds to Celrà’s treatment plant, which 
serves a population of 4638 inhabitants, with a design of 18900 population equivalents, 
and besides municipal sewage, it also receives wastewater from an industrial area, 
where two pharmaceutical industries are located. It should be mentioned that some of 
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these industries have their own treatment systems and therefore, wastewaters that reach 
WWTP2 may have suffered some previous treatment. Finally, the third WWTP 
(WWTP3) corresponds to Castell-Platja d’Aro WWTP, which has a design of 175000 
population equivalents and it mainly treats municipal wastewater from several coastal 
towns. This plant is located in an important touristic area in Costa Brava (one of the 
most important touristic areas along the Spanish Mediterranean coast). 
All three WWTP have a primary and secondary treatment operating with conventional 
activated sludge (CAS). Furthermore, WWTP2 and WWTP3 have also a tertiary 
treatment with UV radiation, but in WWTP2 it only operates for internal recirculation.
It should be worth mentioning that in WWTP3 an MBR-RO pilot plant is installed, 
which treats the secondary effluent of CAS treatment.
Furthermore, WWTP1 operates with a hydraulic retention time of 27 hours, whereas
WWTP2 and WWTP3 uses 48 hours and 14 hours respectively. Influent and effluent 
wastewaters were collected as 24h composite samples, except for WWTP3, where it 
was not possible to achieve composite samples and therefore, grab samples were 
analyzed. Furthermore, in WWTP2 samples were collected flow proportionally. 
Samples from WWTP1 and WWTP3 were collected in December 2011, whereas 
samples from WWTP2 were taken in January 2012. Moreover, for WWTP2 samples 
after tertiary treatment with UV were analyzed. 
Hospital, waste and river waters selected are significant regarding the occurrence of 
antibiotics. On one hand, hospital wastewaters analyzed correspond to an important 
hospital, where it is expected that a wide range of antibiotics are used on a daily basis. 
Moreover, WWTP selected besides urban wastewater (WWTP3), they receive hospital 
(WWT1) and industrial wastewater (WWTP2), which may be important sources of 
contamination by antibiotics of human consumption mainly. 
Concerning river waters, five samples have been determined, all of them corresponding 
to the river Ter (TR1_A, TR1_B, TR2_A, TR2_B and TR2_C). The river Ter starts in 
Ulldeter, at 2400 meters height, and it travels across important rural areas in Catalonia 
(North East of Spain), such as Ripollès, Osona, Selva, Gironès and Baix Empordà. 
Moreover, this river is one of the main rivers that crosses Girona city before flowing 
into the Mediterranean Sea. Due o its trajectory, it is expected to detect antibiotics of 
both human and veterinary use. Then, TR1_A and TR2_A correspond to sampling 
points located before WWTP1 and WWTP2, respectively, whereas TR1_B and TR2_B 
are referred to the sampling points located at the point of discharge of WWTP1 and 
WWTP2, respectively. Finally TR2_C is located 1000 meters downstream WWTP2. 
Levels of antibiotics detected in hospital and urban wastewaters are summarized in
table 5, whereas levels found in river waters are depicted in figure 4. Concerning 
hospital wastewaters, approximately 14 compounds out of the 53 antibiotics 
investigated were detected. Antibiotics found at highest concentrations corresponded to 
the fluoroquinolone antibiotics ofloxacin (from around 3 to 10 μg/L) and ciprofloxacin 
(from approximately 5 to 8 μg/L). The lincosamide clindamycin was also detected at 
high concentrations during the first sampling (1.5 μg/L), followed by hydroxyl-
metranidazole and metranidazole (0.9 and 0.6 μg/L, respectively). It is worth 
mentioning that hydroxyl-metronidazole was detected at significant concentrations 
being even more prominent than the parent antibiotic and that, to the author’s 
knowledge, this is the first study reporting the occurrence of hydroxymetronidazole in 
wastewater samples. Other antibiotics found at significant concentrations were the 
macrolides azithromycin and clarithromycin (from approximately 100 ng/L up to 1 μg/L 
for clarithromycin in the second sampling campaign). Sulfamethoxazole and 
trimethoprim were also found but at lower concentrations (from approximately 50 to 
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200 ng/L). Significant differences in antibiotic concentrations between sampling 
campaigns were observed, which is not surprising since different usage of antibiotics is 
expected along the days. In fact, in a study conducted by Lindberg et al. [39] significant 
differences in antibiotic concentrations were observed within the same day. However, a 
similar antibiotic residue profile was detected in the two sampling campaigns, which 
can give information about antibiotic usage and consumption in this hospital. 
Concentration levels detected are in good agreement with those found in the scientific 
literature. Verlicchi et al. in a review paper [42] reported high levels for ciprofloxacin 
and ofloxacin as well, between 10 ng/L up to 100 μg/L and from approximately 0.5 
μg/L to more than 10 μg/L, respectively. Moreover, in this review paper, the authors 
gave a list of the pharmaceutical classes most frequently found in hospital wastewaters, 
being fluoroquinolones, penicillins, lincosamides, sulfamethoxazole, tetracyclines and 
trimetoprim the most ubiquitous antibiotics. On the other hand, Won-Jin et al. [46]
analyzed a wide range of pharmaceuticals, including antibiotics, in household, hospital, 
livestock and municipal wastewater, and they also found high concentrations for 
ciprofloxacin (median concentration of 3 μg/L). The other antibiotics that they found 
were sulfamethoxazole (with a concentration range from 0.1 to 4 μg/L), trimethoprim 
(from 0.02 to 95 μg/L) and lincomycin (from 0.2 to 48 μg/L). Another representative 
study is the aforementioned manuscript of Lindberg et al. [39], who detected 
concentrations of ofloxacin, ciprofloxacin, sulfamethoxazole, trimethoprim, 
metronidazole and doxycycline in the high μg/L range (from 2 up to 100 μg/L) in 
hospital wastewater samples. 
Regarding urban wastewaters, between 11 and 14 out of the 53 antibiotic compounds 
investigated were detected in influent wastewaters whereas nearly 11 out of the 53 were 
found in effluent wastewaters. Regarding the effluent wastewater after tertiary 
treatment, a similar number of antibiotics than in effluent wastewaters after biological 
treatment were detected and at similar concentrations. Levels found in these matrices 
were in the high ng/L range, and as expected, lower than in hospital wastewaters. Even 
though concentrations found in influent wastewaters were much higher than the ones 
found in effluents, still significant levels (in the low and high ng/L range) were detected 
in these treated waters (see table 5). Higher levels in influent and effluent wastewaters 
in all WWTP were found for the fluoroquinolones ciprofloxacin and ofloxacin (and 
norfloxacin only in WWTP2), macrolides azithromycin and clarithromycin, the 
sulfonamide sulfamethoxazole, the hydrofolase reductase inhibitor trimethoprim and the 
nitroimidazole antibiotics metronidazole and its metabolite hydroxylmetronidazole.  It 
is worth mentioning that hydroxymetronidazole was found in both influent and effluent 
wastewaters from WWTP1 and WWTP3 at significant concentrations, equal or even 
more prominent than the parent compound.
On the other hand, tertiary treatment applied in WWTP2, which consists of UV 
disinfection, did not have a significant effect in further mitigating the antibiotics 
concentrations found in effluent wastewaters after biological treatment, since similar 
concentrations have been found in both matrices. These findings are also in good 
agreement with a study conducted by Radjenovic et al [47], where it was found that 
pharmaceuticals, and among this group some antibiotics were studied, were not 
removed from drinking water after UV radiation. This was attributed to the fact that the 
UV dose applied for disinfection was insufficient for the breakdown of low molecular 
weight compounds [48]. In another study conducted by Prados-Joya et al. [49], where 
they investigated the efficiency of UV radiation in the direct photodegradation of 
nitroimidazole antibiotics, it was also concluded that the dose habitually used for water
disinfection is not sufficient to remove this type of compounds. 
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Regarding river waters, and as expected, concentrations found were much lower than 
the ones detected in wastewaters, indicating that an important dilution factor occurs 
once antibiotics enter river waters (see figure 4). In a great extent, concentrations found 
ranged from 1-3 ng/L to nearly 200 ng/L. Like in wastewaters, antibiotics most 
frequently detected and at highest concentrations were the fluoroquinolones ofloxacin 
and ciprofloxacin, the macrolides azithromycin and clarithromycin, the lincosamides 
clindamycin, the sulfonamide sulfamethoxazole, the hydrofolase reductase trimethoprim 
and the nitroimidazole metronidazole. Furthermore, like in wastewaters, quinolone 
antibiotics were also detected but at much lower concentrations (from 2 to 10 ng/L 
approximately).
Concentration levels found in river water samples before and after wastewater treatment 
plants are very similar for the vast majority of antibiotics, except for ofloxacin, 
azithromycin, clarithromycin and sulfamethoxazole in TR1 samples (see figure 4A) and 
for azythromycin in TR2 samples (see figure 4B). For these particular substances, 
WWTP effluents might have an important contribution to their occurrence in river 
waters. However, no firm conclusions on the effect of WWTP as main sources of 
antibiotic contamination in river waters can be drawn for the other antibiotics. 
Antibiotics present in the samples located before the wastewater treatment plants may 
come from both urban and veterinary sources, since as previously mentioned, river Ter 
crosses rural areas along its trajectory. 
Finally, similar concentrations than the ones presented here have been reported by 
several monitoring programs conducted in different countries where they analyzed 
urban wastewater and river waters [43,50,51]. 
Conclusions
The multi-residue analytical method developed, based on automated off-line SPE-
UHPLC-MS/MS (QqLIT) allowed the simultaneous extraction of a wide spectrum of 
multiple-class antibiotics and some representative metabolites in hospital and urban 
wastewater as well as in river water. The inclusion of relevant antibiotic metabolites in 
analytical methods is important in order to have a complete picture about their 
environmental occurrence, fate and risks. The method developed present several 
advantages such as high throughput, due to the minimization of sample manipulation 
and the use of ultra-high- erformance liquid chromatography, which speeds up 
chromatographic analysis and separation of target antibiotics is performed with high 
resolution; the inclusion of relevant metabolites; high sensitivity and selectivity, due to 
the use of last generation, cutting-edge hybrid tandem mass spectrometers, such as the 
quadrupole-linear ion trap tandem mass spectrometry; and finally, good analytical 
performances within the multi-residue method for ß-lactam antibiotics (penicillins and 
cephalosporines). The method developed yielded limits of detection in the low ng/L 
range for complex environmental matrices, such as hospital and urban wastewaters, and 
also for river waters, thus providing a reliable and robust tool that can be used for 
routine analysis of multiple-class antibiotics in aqueous samples. Indeed, this method 
can be valuable to support studies dealing with the occurrence of antibiotic resistance in 
environmental waters polluted by antibiotic residues. Finally, the application of the 
method to the analysis of hospital, municipal wastewater and river water showed that 
antibiotics are quite ubiquitous pollutants in such matrices. The high concentrations 
found in hospital wastewaters and the low removal rates achieved during conventional 
wastewater treatment indicate that both hospital and urban wastewater are an important 
source of antibiotic pollution in the aquatic environment. Even though levels found in 
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wastewaters were in the low μg/L and high ng/L range, an important dilution occurs in 
river waters, leading to low ng/L levels detected. 
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Figure captions
Figure1. Recoveries obtained for selected antibiotics in Milli-Q-water using Oasis HLB 
cartridges, with and without sample pH adjustment, and Oasis MCX cartridges. 
Figure2. Representative total ion current (TIC) chromatograms of (A) a 50 ng/mL 
standard mixture of antibiotics and chromatograms showing some of the most 
ubiquitous compounds detected in (B) an urban influent wastewater and (C) a river 
water sample. 
Figure3. Matrix effects evaluation. Bars show the percentage of signal reduction 
(ionization suppression) for some representative antibiotics in (A) hospital wastewater 
and (B) urban influent wastewater. 
Figure4. Concentration levels of the antibiotic residues detected above the method 
limits of quantification in the river Ter (A) at the sampling locations before and after 
WWTP1 and (B) at the sampling points before and after WWTP2 and 1km downstream.   
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Table1. Antibiotics analyzed, classified by their chemical group, and the isotopically 
labelled internal standards assigned for their quantification. 
Chemical group Compounds Number Chemical formula
Corresponding internal 
standard
Ofloxacin 1 C18H20FN3O4 Ofloxacin-d3
Ciprofloxacin 2 C17H18N3FO3 Ciprofloxacin-d8
Enrofloxacin 3 C19H22FN3O3 Ofloxacin-d3
Danofloxacin 4 C19H20FN3O3 Ofloxacin-d3
Norfloxacin 5 C16H18N3FO3 Ofloxacin-d3
Orbifloxacin 6 C19H20F3N3O3 Ofloxacin-d3
Marbofloxacin 7 C17H19FN4O4 Ofloxacin-d3
Fluoroquinolones 
Cinoxacin 9 C12H10N2O5 Ofloxacin-d3
Flumequine 10 C14H12FNO3 Ofloxacin-d3
Oxolinic acid 11 C13H11NO5 Ofloxacin-d3
Nalidixic acid 12 C12H12N2O3 Ofloxacin-d3
Quinolones
Pipemidic acid 13 C14H17N5O3 Ofloxacin-d3
Penicillins Amoxicillin 14 C16H19N3O5S Ampicillin-
15N
Ampicillin 15 C16H19N3O4S Ampicillin-
15N
Penicillin G 16 C16H17N2O4S Ampicillin-
15N
Penicillin V 17 C16H17N2O5S Ampicillin-
15N
Oxacillin 19 C19H18N3O5S Ampicillin-
15N
Cephalosporins Cefalexin 20 C16H17N3O4S Ampicillin-
15N
Cefazolin 21 C14H13N8O4S3 Ampicillin-
15N
Cefotaxime 22 C16H16N5O7S2 Ampicillin-
15N
Cefuroxime 23 C16H16N4O8S Ampicillin-
15N
Ceftiofur 24 C19H17N5O7S3 Ampicillin-
15N
Cefapirin 25 C17H16N3O6S2 Ampicillin-
15N
Macrolides Azithromycin 27 C38H72N2O12 Azithromycin-d3
Clarithromycin 28 C38H69NO13 Azithromycin-d3
Roxithromycin 29 C41H76N2O15 Azithromycin-d3
Tylosin 30 C46H77NO17
Azithromycin-d3 or
Lincomycin-d3
Tilmicosin 31 C46H80N2O13
Azithromycin-d3 or
Lincomycin-d3
Spiramycin 32 C43H74N2O14
Azithromycin-d3 or
Lincomycin-d3
Tetracycline 33 C22H24N2O8 Sulfamethoxazole-d4
Chlortetracyline 34 C22H23ClN2O8 Sulfamethoxazole-d4
Doxycycline 35 C22H24N2O8 Sulfamethoxazole-d4
Tetracyclines
Oxytetracycline 36 C22H24N2O9 Sulfamethoxazole-d4
Clindamycin 37 C18H33ClN2O5S Lincomycin-d3Lincosamides
Lincomycin 38 C18H34N2O6S Lincomycin-d3
Sulfonamides Sulfamethoxazole 39 C10H11N3O3S Sulfamethoxazole-d4
Sulfadiazine 40 C10H10N4O2S Sulfamethoxazole-d4
Sulfisomidin 41 C12H14N4O2S Sulfamethoxazole-d4
Sulfathiazole 42 C9H9N3O2S2 Sulfamethoxazole-d4
Sulfadimethoxine 43 C12H14N4O4S Sulfamethoxazole-d4
Sulfapyridine 44 C11H11N3O2S Sulfamethoxazole-d4
Sulfamerazine 45 C11H12N4O2S Sulfamethoxazole-d4
Sulfamethizole 46 C9H10N4O2S2 Sulfamethoxazole-d4
Sulfamethoxypiridazine 47 C11H12N4O3S Sulfamethoxazole-d4
Sulfisoxazole 48 C11H13N3O3S Sulfamethoxazole-d4
Sulfanitran 49 C14H13N3O5S Sulfamethoxazole-d4
Sulfabenzamide 50 C13H12N2O3S Sulfamethoxazole-d4
N-acetylsulfadiazine* 51 C12H12N4O3S Sulfamethoxazole-d4
N-acetylsulfamethazine* 52 C14H16N4O3S Sulfamethoxazole-d4
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N-acetylsulfamerazine* 54 C13H14N4O3S Sulfamethoxazole-d4
Dihydrofolate 
reductase 
inhibitors
Trimethoprim
55
C14H18N4O3 Sulfamethoxazole-d4
Metronidazole 56 C6H9N3O3 Ronidazole-d3Nitroimidazole 
antibiotics Metronidazole-OH* 57 C6H9N3O4 Ronidazole-d3
*metabolites
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Table2. Target antibiotics, classified by their chromatographic retention time, and their 1
optimized UPLC-QqLIT-MS/MS parameters by positive ionization mode2
3
Antibiotics
Rt 
(min)
Precursor ion (m/z) Q3 DP/CE/CXP Q3 DP/CE/CXP
Metronidazole-OH 0.74 188 [M+H]+ 126 51/23/18 123 51/19/16
Amoxicillin 0.74 366 [M+H]+ 349 56/13/50 114 56/27/18
Ronidazole-d3 (IS) 0.83 204 [M+H]
+ 160 261/41/26 - -
Metronidazole 0.84 172 [M+H]+ 82 56/35/10 128 51/21/10
Cefuroxime 0.87 425 [M+H]+ 364 81/21/16 321 76/17/14
Cefapyrin 0.87 423 [M+H]+ 124 81/63/12 152 81/33/14
Sulfisomidin 0.90 279 [M+H]+ 186 76/25/16 65 76/73/8
Lincomycin 0.96 407 [M+H]+ 359 96/27/12 389 96/25/12
Lincomycin-d3 (IS) 0.96 410 [M+H]
+ 129 56/37/14 - -
Pipemidic acid 1.00 304 [M+H]+ 217 101/33/12 304 101/45/18
Sulfadiazine 1.00 251 [M+H]+ 156 56/23/14 92 56/37/12
Ampicillin 1.06 350 [M+H]+ 106 116/35/20 114 116/41/18
Ampicillin-15N (IS) 1.06 351 [M+H]+ 107 91/39/16 - -
Sulfathiazole 1.07 256 [M+H]+ 156 66/21/22 92 66/39/10
Cefalexin 1.08 348 [M+H]+ 158 31/15/24 106 31/43/12
Sulfapyridine 1.10 250 [M+H]+ 156 51/23/16 92 51/37/14
Trimethoprim 1.10 291 [M+H]+ 230 91/33/12 261 91/35/10
Marbofloxacin 1.11 363 [M+H]+ 72 86/27/10 320 86/23/12
Norfloxacin 1.14 320 [M+H]+ 276 106/25/12 233 106/35/34
N-acetylsulfadiazine 1.14 293 [M+H]+ 65 56/59/12 134 56/33/18
Ofloxacin-d3 (IS) 1.15 365 [M+H]
+ 321 96/27/12 - -
Ofloxacin 1.16 362 [M+H]+ 318 86/27/12 261 86/39/12
Oxytetracycline 1.16 461 [M+H]+ 426 71/29/16 443 71/19/16
Ciprofloxacin-d8 (IS) 1.16 340 [M+H]
+ 296 86/27/12 - -
Sulfamerazin 1.17 265 [M+H]+ 156 66/23/14 92 66/41/14
Ciprofloxacin 1.18 332 [M+H]+ 288 66/27/12 245 66/33/16
Cefotaxime 1.18 456 [M+H]+ 125 86/77/10 167 86/27/22
N-acetylsulfamerazine 1.21 307 [M+H]+ 65 96/67/10 134 96/35/10
Danofloxacin 1.22 358 [M+H]+ 340 96/35/12 314 96/27/12
Tetracyclin 1.25 445 [M+H]+ 410 101/27/14 154 76/37/18
Enrofloxacin 1.27 360 [M+H]+ 316 76/27/12 245 76/39/12
N-acetylsulfamethazine 1.29 321 [M+H]+ 65 81/65/10 134 81/37/14
Orbifloxacin 1.30 396 [M+H]+ 352 91/27/12 295 91/35/12
Sulfamethizole 1.32 271 [M+H]+ 156 21/21/14 92 21/41/8
Cefazolin 1.33 455 [M+H]+ 323 61/17/12 156 61/21/18
Sulfamethoxipyridazine 1.34 281 [M+H]+ 156 66/25/12 92 66/39/10
Spiramycin 1.42 843 [M+H]+ 174 16/47/14 43 16/129/8
Azithromycin 1.43 749 [M+H]+ 591 121/41/22 116 121/48/13
Azithromycin-d3 (IS) 1.43 752 [M+H]
+ 594 01/43/22 - -
Chlortetracycline 1.52 479 [M+H]+ 444 51/31/18 260 51/77/42
Clindamycin 1.53 425 [M+H]+ 126 96/35/12 377 106/27/12
Doxycycline 1.59 445 [M+H]+ 154 76/37/18 429 76/17/14
Sulfadoxine-d3 (surrogate) 1.60 314 [M+H]
+ 156 51/25/12 - -
Tilmicosin 1.63 869 [M+H]+ 88 26/119/16 696 26/57/26
Cinoxacin 1.64 263 [M+H]+ 245 56/21/10 189 56/39/16
Sulfamethoxazole-d4 (IS) 1.64 258 [M+H]
+ 160 101/23/18 - -
Sulfamethoxazole 1.65 254 [M+H]+ 156 81/23/12 92 81/37/12
Sulfisoxazole 1.73 268 [M+H]+ 156 76/19/20 113 76/23/16
Ceftiofur 1.74 524 [M+H]+ 125 66/91/14 241 66/25/10
Oxolinic acid 1.78 262 [M+H]+ 160 76/51/20 216 76/41/34
Sulfabenzamide 1.86 277 [M+H]+ 156 56/19/24 92 56/39/14
Sulfadimethoxine-d6
(surrogate)
1.87
317 [M+H]+ 162 61/33/8 - -
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Sulfadimethoxine 1.89 311 [M+H]+ 156 71/29/14 65 71/79/10
Tylosin 1.95 916 [M+H]+ 174 21/43/30 772 21/49/14
Penicillin G 2.03 335 [M+H]+ 176 96/19/22 160 96/21/8
Nalidixic acid 2.12 233 [M+H]+ 215 46/25/18 187 46/37/16
Clarithromycin 2.16 748 [M+H]+ 158 96/37/14 590 96/27/22
Penicillin V 2.19 351 [M+H]+ 160 41/17/14 114 41/49/18
Roxithromycin 2.19 837 [M+H]+ 679 91/31/26 158 91/43/14
Flumequine 2.20 262 [M+H]+ 244 01/29/36 202 01/43/28
Sulfanitran 2.22 336 [M+H]+ 156 96/21/14 134 96/35/16
Oxacillin 2.32 402 [M+H]+ 144 146/33/22 77 146/91/12
Table3. Analytical method validation parameters: recoveries obtained for target 1
antibiotics in different water matrices (HWW: hospital wastewater; UWWI: urban 2
wastewater influent; UWWE: urban wastewater effluent; RW: river water), instrumental 3
detection limits (IDLs), linearity, repeatability (run-to-run analysis) and reproducibility4
(day-to-day analysis)5
6
% Recoveries (% RSD) (n=3)
IDL 
(pg injected)Chemical groups Antibiotics
HWW UWWE UWWI RW
Ofloxacin 68 (±31.8) 115 (±18.2) 113 (±28.2) 55 (±2.8) 1.51
Ciprofloxacin 137 (±11.9) 136 (±18.7) 163 (±10.8) 55 (±8.0) 2.50
Enrofloxacin 68 (±3.4) 133 (±12.2) 112 (±8.0) 85 (±5.8) 0.49
Danofloxacin 73 (±2.8) 150 (±15.4) 131 (±4.1) 108 (±17.7) 3.30
Norfloxacin 189 (±5.4) 142 (±11.4) 153 (±11.6) 121 (±5.0) 5.45
Orbifloxacin 30 (±2.9) 50 (±11.2) 40 (±6.4) 51 (±10.3) 0.25
Marbofloxacin 53 (±4.8) 79 (±11.7) 70 (±1.6) 94 (±3.9) 0.66
Fluoroquinolones
Cinoxacin 30 (±5.1) 55 (±10.7) 44 (±16.9) 94 (±3.9) 0.5
Flumequine 85 (±0.3) 119 (±11.9) 111 (±1.9) 119 (±10.4) 0.15
Oxolinic acid 30 (±6.6) 132 (±11.9) 117 (±1.2) 119 (±10.4) 0.23
Nalidixic acid 60 (±5.5) 110 (±11.3) 101 (±2.5) 104 (±4.5) 0.20
Quinolones
Pipemidic acid 176 (±16.3) 95 (±17.4) 119 (±5.3) 75 (±15.6) 2.0
Amoxicillin 126 (±15.6) 20 (±9.9) 20 (±9.1) 20 (±10.4) 0.20
Ampicillin 78 (±5.2) 80 (±11.2 94 (±11.2) 108 (±3.9) 0.05
Penicillin G 33 (±4.3) 30 (±21.5) 30 (±16.3) 50 (±20.0) 0.25
Penicillin V 40 (±1.1) 136 (±1.6) 111 (±20.0) 97 (±10.7) 0.10
Penicillins
Oxacillin 75 (±8.5) 54 (±4.8) 40 (±7.4) n.c. 0.50
Cefalexin 50 (±3.7) 63 (±6.9) 83 (±9.4) 69 (±13.6) 0.25
Cefazolin 93 (±9.5) 118 (±10.8) 118 (±10.8) 131 (±2.2) 5.0
Cefotaxime 101 (±1.0) 90 (±6.5) 125 (±7.4) 70 (±12.0) 0.10
Cefuroxime 104 (±10.7) 127 (±17.5) 71 (±8.2) 133 (±10.2) 2.00
Ceftiofur 40 (±3.5) 50 (±7.3) 64 (±9.4) 77 (±6.1) 0.10
Cephalosporines
Cefapirin 129 (±2.1) 80 (±8.0) 95 (±15.7) 70 (±12.0) 0.10
Azithromycin 108 (±26.0) 108 (±20.0) 81 (±2.5) 60 (±5.8) 0.25
Clarithromycin 73 (±2.3) 138 (±15.6) 115 (±13.1) 66 (±6.5) 0.30
Roxithromycin 50 (±1.0) 133 (±1.6) 105 (±3.0) 95 (±3.4) 0.11
Tylosin 50 (±4.5) 142 (±1.0) 137 (±1.2) 70 (±4.1) 1.04
Tilmicosin 95 (±7.8) 156 (±1.0) 155 (±11.0) 160 (±17.1) 1.00
Macrolides
Spiramycin 145 (±23.4) 73 (±2.1) 50 (±1.0) 84 (±14.5) 5.00
Tetracycline 70 (±2.9) 114 (±3.2) 117 (±12.2) 108 (±9.2) 0.30
Chlortetracyline 104 (±5.7) 98 (±7.6) 102 (±25.1) 108 (±3.1) 0.60
Doxycycline 50 (±7.4) 125 (±11.7) 117 (±1.84) 76 (±18.34) 5.0
Tetracyclines
Oxytetracycline 80 (±0.2) 150 (±4.2) 180 (±4.12) 88 (±8.0) 0.25
Clindamycin 88 (±7.0) 118 (±10.8) 131 (±3.2) 107 (±5.7) 0.05
Lincosamides
Lincomycin 70 (±1.7) 63 (±4.5) 98 (±3.7) 82 (±20.0) 0.25
Sulfamethoxazole 60 (±13.8) 63 (±4.5) 98 (±3.7) 89 (±15.0) 0.05
Sulfadiazine 40 (±9.2) 64 (±7.0) 90 (±4.5) 50 (±18.0) 0.1
Sulfonamides
Sulfisomidin 79 (±5.7) 50 (±4.4) 60 (±6.9) 50 (±18.6) 0.1
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Sulfathiazole 50 (±4.8) 50 (±2.0) 77 (±9.0) 70 (±19.0) 0.05
Sulfadimethoxine 113 (±7.5) 81 (±14.0) 90 (±5.5) 50 (±16.0) 0.05
Sulfapyridine 71 (±6.8) 50 (±14.0) 71 (±8.1) 60 (±18.0) 0.10
Sulfamerazine 63 (±11.9) 51 (±6.3) 80 (±7.3) 72 (±15.0) 0.10
Sulfamethizole 50 (±4.1) 50 (±4.1) 81 (±4.9) 64 (±13.3) 0.05
Sulfamethoxypiridazine 40 (±11.0) 50 (±3.7) 74 (±8.8) 76 (±17.0) 0.05
Sulfisoxazole 50 (±11.0) 60 (±13.3) 80 (±4.4) 50 (±16.3) 0.10
Sulfanitran 100 (±1.1) 100 (±1.1) 95 (±3.5) 100 (±15.0) 0.50
Sulfabenzamide 70 (±13.0) 60 (±4.0) 80 (±2.0) 71 (±13.0) 0.10
N-acetylsulfadiazine* 83 (±2.4) 109 (±6.9) 126 (±8.4) 89 (±20.0) 0.50
N-acetylsulfamethazine* 93 (±7.3) 105 (±1.9) 80 (±14.3) 104 (±11.4) 0.10
N-acetylsulfamerazine* 109 (±3.6) 89 (±6.4) 64 (±7.8) 90(±3.3) 0.25
Dihydrofolate 
reductase 
inhibitors
Trimethoprim 122 (±8.5) 84 (±7.6) 74 (±6.1) 102 (±8.6) 0.05
Metronidazole 51 (±9.6) 55 (±3.9) 78 (±5.6) 30 (±20.0) 0.25Nitroimidazole 
antibiotics Metronidazole-OH* 20 (±15.0) 20 (±15.0) 40 (±10.1) n.c. 0.25
1
n.c.: value not calculated for this specific matrix; compounds with this “*” symbol are antibiotic 2
metabolites. 3
4
5
6
7
Table4. Analytical method validation parameters: Method detection and quantification 8
limits (MDL, MQL) in all matrices studied. 9
10
MDL (ng/L)
Chemical groups
Antibiotics
HWW UWWE UWWI RW HWW
Ofloxacin 15,70 6,44 13,81 2,54 52,32
Ciprofloxacin 8,95 5,55 13,58 1,71 29,84
Enrofloxacin 7,58 7,73 8,42 0,54 25,28
Danofloxacin 11,93 47,43 34,35 13,55 39,78
Norfloxacin 28,75 55,11 77,71 2,53 95,84
Orbifloxacin 1,19 2,67 3,82 0,65 3,97
Marbofloxacin 4,31 2,23 4,02 2,50 14,37
Fluoroquinolones
Cinoxacin 1,80 6,12 15,64 5,52 6,00
Flumequine 2,68 3,17 4,25 0,73 8,94
Oxolinic acid 2,45 16,45 19,60 2,62 8,15
Nalidixic acid 1,71 10,56 7,92 1,77 5,71
Quinolones
Pipemidic acid 5,24 6,02 16,87 3,31 17,45
Amoxicillin 9,49 2,65 3,32 1,32 31,63
Ampicillin 4,56 3,08 2,73 0,83 15,20
Penicillin G 2,55 3,48 8,62 4,00 8,51
Penicillin V 11,31 7,04 22,82 5,37 37,71
Penicillins
Oxacillin 48,32 34,63 49,43 n.c. 161,08
Cefalexin 4,32 1,43 3,40 0,77 14,41
Cefazolin 49.21 54,11 39,81 13.37 164.02
Cefotaxime 22,52 5,16 19,47 2,82 75,06
Cefuroxime 24,04 26,90 22,90 5,48 80,13
Ceftiofur 3,84 5,32 8,31 1,26 12,80
Cephalosporines
Cefapirin 18,54 10,70 18,49 2,37 61,80
Azithromycin 4.04 4,63 3,26 0,61 13.46
Clarithromycin 2,93 9,13 16,64 0,35 9,77
Roxithromycin 8,50 8,71 5,80 0,31 28,35
Tylosin 11,97 28,11 34,00 2,37 39,90
Macrolides
Tilmicosin 7.50 7,68 17,82 3,73 25.01
Page 27 of 35
Ac
ce
pte
d M
an
us
cri
pt
Spiramycin 12.16 13,20 26,41 3,99 40.53
Tetracycline 24,30 13,42 16,25 4.72 81,00
Chlortetracyline 17,72 13,77 24,02 11,20 59,08
Doxycycline 33,65 77,49 59,79 11,23 112,16
Tetracyclines
Oxytetracycline 3,75 5,91 6,01 4,40 12,51
Clindamycin 4,89 1,48 3,13 0,48 16,29
Lincosamides
Lincomycin 9,13 11,24 17,82 6,04 30,44
Sulfamethoxazole 3,78 4,78 8,07 1,39 12,60
Sulfadiazine 5,92 11,14 11,25 3,35 19,73
Sulfisomidin 11,76 5,16 17,58 5,49 39,21
Sulfathiazole 8,55 6,80 14,40 2,03 28,48
Sulfadimethoxine 16,17 9,67 11,53 0,41 53,90
Sulfapyridine 3,05 2,79 4,33 1,82 10,15
Sulfamerazine 19,24 8,74 16,66 2,37 64,14
Sulfamethizole 11.76 5.16 18 5.49 39.21
Sulfamethoxypiridazine 5,00 5,17 7,97 0,81 16,66
Sulfisoxazole 4,42 2,57 6,62 0,87 14,75
Sulfanitran n.c. 10,93 16,86 5,16 n.c.
Sulfabenzamide 3,06 1,92 2,94 0,75 10.21
N-acetylsulfadiazine* 25,21 14,36 34,48 3,41 84,05
N-acetylsulfamethazine* 7,45 7,67 16,19 4,72 24,84
Sulfonamides
N-acetylsulfamerazine* 33,73 19,40 24,63 4,14 112,43
Dihydrofolate 
reductase 
inhibitors
Trimethoprim 11,50 2,35 10,26 1,71 38,34
Metronidazole 6,49 1,80 4,45 0,43 21,64Nitroimidazole 
antibiotics Metronidazole-OH* 6,34 5,20 6,36 n.c. 21,15
1
2
3
4
5
6
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Table5. Concentrations of antibiotics, expressed in ng/L, detected in hospital 1
wastewater, in urban influent and effluent wastewaters and in river waters analyzed. 2
3
Compounds Hospital wastewater WWTP1 WWTP2 WWTP3
HW_A
November 
2011
HW_B
December 
2011
Influent Effluent Influent
Effluent
Biological 
treatment
Effluent 
tertiary 
treatment
Influent Effluent
Ofloxacin 10368 2978 524 67 162 96 101 73 63
Ciprofloxacin 7494 5329 613 nd 445 133 147 185 54
Enrofloxacin nd nd nd nd 58 <MQL 52 nd nd
Danofloxacin nd nd nd nd nd nd nd nd nd
Norfloxacin 327 nd nd nd 385 149 107 nd nd
Orbifloxacin nd nd nd nd nd nd nd nd nd
Marbofloxacin nd nd nd nd 39 16 96 nd nd
Cinoxacin nd nd nd nd nd nd nd nd nd
Flumequine nd <MQL nd <MQL <MQL nd nd <MQL <MQL
Oxolinic acid nd nd nd nd nd nd nd nd nd
Nalidixic acid <MQL <MQL nd nd nd nd nd nd nd
Pipemidic acid nd nd nd nd nd <MQL <MQL nd nd
Amoxicillin <MQL 218 nd nd nd 216 258 nd nd
Ampicillin nd nd nd nd nd nd nd nd nd
Penicillin G nd nd nd nd nd nd nd nd nd
Penicillin V nd nd nd nd nd nd nd nd nd
Oxacillin nd nd nd nd nd nd nd nd nd
Cefalexin nd nd nd nd nd nd nd nd nd
Cefazolin nd nd nd nd nd nd nd nd nd
Cefotaxime nd 89 nd nd nd nd nd nd nd
Cefuroxime nd nd nd nd nd nd nd nd nd
Ceftiofur nd nd nd nd nd nd nd nd nd
Cefapirin nd nd nd nd nd nd nd nd nd
Azithromycin 113 85 437 403 nd 225 184 299 592
Clarithromycin 113 973 632 172 185 201 194 241 229
Roxithromycin nd nd nd nd <MQL nd nd <MQL nd
Tylosin nd nd nd nd nd nd nd nd nd
Tilmicosin nd nd nd nd nd nd nd nd nd
Spiramycin nd nd nd nd nd nd nd nd nd
Tetracycline nd nd <MQL <MQL nd nd nd <MQL nd
Chlortetracyline nd nd nd nd nd nd nd nd nd
Doxycycline nd nd nd nd nd nd nd nd nd
Oxytetracycline nd nd nd nd nd nd nd nd nd
Clindamycin 1465 184 37 57 31 21 22 14 18
Lincomycin 119 nd nd nd nd 81 100 nd nd
Sulfamethoxazole 65 200 528 198 43 32 27 180 19
Sulfadiazine nd nd nd nd nd nd nd nd nd
Sulfisomidin nd nd nd nd nd nd nd nd nd
Sulfathiazole nd nd nd nd nd nd nd nd nd
Sulfadimethoxine nd nd nd nd nd nd nd nd nd
Sulfapyridine <MQL nd 32 59 <MQL nd nd 159 98
Sulfamerazine nd nd nd nd nd nd nd nd nd
Sulfamethizole nd nd nd nd nd nd nd nd nd
Sulfamethoxypiridazine nd nd nd nd nd nd nd nd nd
Sulfisoxazole nd nd nd nd nd nd nd nd nd
Sulfanitran nd nd nd nd nd nd nd nd nd
Sulfabenzamide nd nd nd nd nd nd nd nd nd
N-acetylsulfadiazine* nd nd nd nd nd nd nd nd nd
N-
acetylsulfamethazine*
nd nd nd nd nd nd nd nd nd
Page 29 of 35
Ac
ce
pte
d M
an
us
cri
pt
N-acetylsulfamerazine* nd nd nd nd nd nd nd nd nd
Trimethoprim 216 50 178 108 <MQL <MQL <MQL 67 69
Metronidazole 643 67 316 58 28 20 17 72 83
Metronidazole-OH* 887 150 454 177 nd nd nd 127 99
1
2
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Highlights1
Simultaneous determination of 53 antibiotics and some metabolites. 2
High sample throughput (fast sample preparation and chromatographic separation).3
High sensitivity by using advanced mass spectrometry4
Good analytical performances for ß-lactam antibiotics. 5
Analysis of antibiotics in hospital wastewaters.6
7
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Figure1. Recoveries obtained for selected antibiotics in Milli-Q-water using Oasis HLB 
cartridges, with and without sample pH adjustment, and Oasis MCX cartridges. 
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Figure2. Representative total ion current (TIC) chromatograms of (A) a 50ng/mL 
standard mixture of antibiotics and chromatograms showing some of the most 
ubiquitous compounds detected in (B) an urban influent wastewater and (C) a river 
water sample. 
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Figure3. Matrix effects evaluation. Bars show the percentage of signal reduction 
(ionization suppression) for some representative antibiotics in (A) hospital wastewater 
and (B) urban influent wastewater. 
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Figure4. Concentration levels of the antibiotic residues detected above the method 
limits of quantification in the river Ter (A) at the sampling locations before and after 
WWTP1 and (B) at the sampling points before and after WWTP2 and 1km downstream. 
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